about
Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protectionSphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel DiseaseCharacterization of a sphingosine 1-phosphate receptor antagonist prodrugInduction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2Lysophosphatidic acid (LPA) and angiogenesis.Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.Current and emerging therapies for the treatment of age-related macular degenerationNovel pathways for implantation and establishment and maintenance of pregnancy in mammals.ATX-LPA receptor axis in inflammation and cancer.Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degenerationRegulation of cancer cell migration and invasion by sphingosine-1-phosphateSTAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastomaClinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasisLysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis.A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies.Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system.Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis.Immune regulation by sphingosine 1-phosphate and its receptors.Involvement of vacuolar H(+)-ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720.Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro.Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer.Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway.Sphingosine-1-phosphate is involved in the occlusive arteriopathy of pulmonary arterial hypertension.Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants.Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia.Molecular Regulation of Sprouting Angiogenesis.MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survival.Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients
P2860
Q28235893-93F164B4-27FE-441D-B075-E1EC6531EFB9Q30235011-C134590A-E898-4EA6-8622-350556C9339AQ30425227-2FCAFD2B-579E-4C51-A346-71ADFA065865Q30438371-75AE0E67-B837-4ECB-807C-CD508FC5B992Q30439694-F2C7ACE9-B350-4882-8483-6C11A2443852Q33362774-51703F32-DCD9-4645-B429-B2D38D99811AQ33492370-02E1D1CC-8C6C-4402-B144-0EDB3E476384Q33629101-6EE03CF0-C9AD-4837-8F4E-564F7A697879Q34199719-BFFC5418-A233-4442-A17C-38C16CBB456BQ34678040-3B8476A6-35CA-4F09-B62A-B7E915F7F0FEQ34878519-0447E391-34F0-4DEF-9081-A9A9E1D6EE8EQ34936215-B87DD82A-1455-4234-8613-C881FB1103E8Q35845241-44ED80DA-FF9E-43AD-B2DF-F51F9D7588BEQ36157057-76F98111-7342-48AD-AA3B-1D6A621E8E71Q36330107-B3FAC025-EE73-4B76-80C0-68C6B5892848Q36386459-CBBBB98A-066C-4A62-99E0-DF149DE1794AQ36835151-6B07E6B2-B09B-4A89-AF05-BCC520930005Q37135504-923CC81A-FA1B-4691-A8FC-CAE13DE9B185Q37382152-889489BC-09DF-4B19-A3A0-CB32B057C060Q37527497-D3BB7CB3-634E-4B62-91DF-28775D31B5A4Q37874939-9F2ABE6C-C637-48AD-AB66-9B56A873D647Q37967187-FCC4BF5A-EBB3-4AF2-8223-8CD145DB6348Q38943724-A29A4F58-88BB-4AFB-A764-F695C8676997Q39348586-0AF544AB-FA29-477F-8498-1A8738520B13Q39508380-25E53132-F9F4-4F12-9236-F0844C404C3EQ39957450-658E93B2-1E9B-4DDF-B893-D211DB3D2E12Q41065352-33865C1C-E268-4C25-9753-090D2B9E9D41Q42142782-E7C57148-4206-4404-8C61-FF32867751E5Q47094102-923C70F8-49A8-4A44-B7B2-2E8F300B2059Q50423780-C885B096-A2D5-4F53-989B-3DE51661B5EFQ53576816-18E10C7B-DF37-4D8A-BA6F-2B35886AA82FQ57924377-AD3B74C6-23E3-4935-8E7C-A1C06932BFB0
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Targeting sphingosine-1-phosphate for cancer therapy
@ast
Targeting sphingosine-1-phosphate for cancer therapy
@en
type
label
Targeting sphingosine-1-phosphate for cancer therapy
@ast
Targeting sphingosine-1-phosphate for cancer therapy
@en
prefLabel
Targeting sphingosine-1-phosphate for cancer therapy
@ast
Targeting sphingosine-1-phosphate for cancer therapy
@en
P2860
P921
P356
P1476
Targeting sphingosine-1-phosphate for cancer therapy
@en
P2093
R A Sabbadini
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603400
P407
P577
2006-10-03T00:00:00Z
2006-11-06T00:00:00Z